Results for Glatiramer Acetate (GA) Depot 3 year analysis in RRMS, GA Depot safety results in RRMS and PPMS, and novel anti-BMP for remyelination will be presented ECTRIMS 2019.
source https://finance.yahoo.com/news/mapi-pharma-present-series-recent-110000149.html?.tsrc=rss
blaineonline.finance.blog 